GLP-1 receptor agonists are being studied as a treatment for a variety of substance use disorders (SUDs). This 3-part series looks at the current evidence for the treatment of SUD, alcohol use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback